Immunological changes in liver disease.
作者信息
Sherlock S
出版信息
Proc R Soc Med. 1977 Dec;70(12):851-5. doi: 10.1177/003591577707001207.
Abstract
摘要
相似文献
1
Immunological changes in liver disease.肝脏疾病中的免疫变化。
Proc R Soc Med. 1977 Dec;70(12):851-5. doi: 10.1177/003591577707001207.
2
Immunology of liver disease.肝脏疾病的免疫学
Acta Med Port. 1981(Suppl 2):21-33.
3
"Autoallergic" hepatitis.自身免疫性肝炎
N Engl J Med. 1970 Jan 8;282(2):86-8. doi: 10.1056/NEJM197001082820207.
4
[Antitissue antibodies in hepatology].[肝病中的抗组织抗体]
Gastroenterol Clin Biol. 1985 Aug-Sep;9(8-9):622-9.
5
[Autoantibodies in liver diseases: interpretation and pathogenic importance].[肝脏疾病中的自身抗体：解读与致病重要性]
Gastroenterol Hepatol. 1996 Jun-Jul;19(6):326-33.
6
[Clinical significance of the study of antibodies and complement in chronic hepatopathies].[慢性肝病中抗体与补体研究的临床意义]
Minerva Med. 1978 Aug 18;69(38):2573-9.
7
The immunology of liver disorders.肝脏疾病的免疫学
Proc R Soc Med. 1974 Jun;67(6 Pt 2):566-73. doi: 10.1177/00359157740676P210.
8
Immunopathology of liver disease.肝脏疾病的免疫病理学
Prog Liver Dis. 1972;4:381-402.
9
Characterization of the mononuclear cell infiltrate in piecemeal necrosis.
Lab Invest. 1984 Mar;50(3):247-9.
10
Autoimmunity in liver diseases.肝脏疾病中的自身免疫
Prog Clin Immunol. 1972;1:45-70.
引用本文的文献
1
Plasticity of monocytes and macrophages in cirrhosis of the liver.肝硬化中单核细胞和巨噬细胞的可塑性
Front Netw Physiol. 2022 Jul 15;2:937739. doi: 10.3389/fnetp.2022.937739. eCollection 2022.
2
Evaluation of Evolocumab (AMG 145), a Fully Human Anti-PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic Impairment.在肝功能损害受试者中对全人源抗PCSK9 IgG2单克隆抗体依洛尤单抗（AMG 145）的评估。
J Clin Pharmacol. 2017 Apr;57(4):513-523. doi: 10.1002/jcph.832. Epub 2016 Oct 26.
3
Impaired monocyte function in liver cirrhosis.肝硬化患者单核细胞功能受损。
Br Med J (Clin Res Ed). 1981 Apr 18;282(6272):1262-3. doi: 10.1136/bmj.282.6272.1262.
4
Development of Hodgkin's disease in the course of liver cirrhosis and impaired monocyte function.肝硬化病程中霍奇金淋巴瘤的发生与单核细胞功能受损。
Postgrad Med J. 1984 Jul;60(705):482-4. doi: 10.1136/pgmj.60.705.482.
5
The liver as a barrier against antigens in viral hepatitis infection.
Naturwissenschaften. 1978 Dec;65(12):662-4. doi: 10.1007/BF00401919.
本文引用的文献
1
Paraproteins with antibody activity in acute viral hepatitis and chronic autoimmune liver diseases.具有抗体活性的副蛋白在急性病毒性肝炎和慢性自身免疫性肝病中的作用。
Gut. 1974 May;15(5):396-400. doi: 10.1136/gut.15.5.396.
2
The production of antibody by patients with chronic hepatic disease.慢性肝病患者抗体的产生。
J Immunol. 1951 Oct;67(4):347-56.
3
Immunologic response to tetanus toxoid inoculation in patients with hepatic cirrhosis.
N Engl J Med. 1959 Aug 13;261(7):340-2. doi: 10.1056/NEJM195908132610707.
4
Mitochondrial antibodies in primary biliary cirrhosis. 3. Characterization of the inner-membrane complement fixing antigen.原发性胆汁性肝硬化中的线粒体抗体。3. 内膜补体结合抗原的特性
Clin Exp Immunol. 1969 May;4(5):511-25.
5
6
The effect of colloidal carbon on the organ distribution of sheep red cells and the immune response.胶体碳对绵羊红细胞器官分布及免疫反应的影响。
Immunology. 1972 Apr;22(4):685-94.
7
Impaired delayed hypersensitivity in primary biliary cirrhosis.原发性胆汁性肝硬化中迟发型超敏反应受损。
Lancet. 1969 May 10;1(7602):959-62. doi: 10.1016/s0140-6736(69)91860-1.
8
A unified concept of autoimmune hepatitis.自身免疫性肝炎的统一概念
Lancet. 1969 Apr 19;1(7599):813-5. doi: 10.1016/s0140-6736(69)92072-8.
9
High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis.活动性慢性肝炎或原发性胆汁性肝硬化患者亲属中血清免疫异常的高患病率。
N Engl J Med. 1974 Jan 10;290(2):63-9. doi: 10.1056/NEJM197401102900201.
10
Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.肝脏在控制肠道共生细菌免疫原性中的作用。
Lancet. 1973 Jun 9;1(7815):1288-91. doi: 10.1016/s0140-6736(73)91300-7.
Zotero 插件